• Company
  • Location and Contacts
  • Management
  • Board of Directors
  • Partners
  • Community
  • Careers
• Products
  • RF 300 for in vitro ADME and High Throughput Screening
  • RF 200 for High Throughput Screening
  • Cartridges and Chemistry Products
  • Integrator
• Contract Research
  • Lead Discovery Service
    • Custom Assay Development
    • Primary Screening
    • Secondary Screening
  • In vitro ADME Screening
    • CYP Inhibition
    • Metabolic Stability
• Resources
  • Case Studies
  • Product Literature
  • Journal Articles
  • Presentations
  • Courses
  • Demo Lab
  • FAQs
• News & Events
  • Press Releases
    • Archived Releases
  • In the News
  • Events
  • Blog

• Contract Research
• Lead Discovery Service
  • Custom Assay Development
  • Primary Screening
  • Secondary Screening
• in vitro ADME Screening
  • CYP Inhibition
  • Metabolic Stability

Home Page / Contract Research ...

Contract Research

Higher throughput, better data, rapid turn-around times. Faster Answers

BIOCIUS provides custom assay development and screening services utilizing proprietary RapidFire technology. The label-free technology is amenable to a host of compounds and targets including those which are difficult or impossible to screen using traditional optical technologies. Very fast turn-around times enable important decisions on pharmaceutical compounds earlier in the drug discovery process.

BIOCIUS offers both lead discovery and in vitro ADME screening services.

BIOCIUS. Faster Answers.

RapidFire® technology is described in patent numbers 6,932,939, 6,812,030 7,100,460, 7,588,725,